Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.58 EUR | -1.27% | +2.63% | +6.19% |
Apr. 30 | Transcript : Metrovacesa S.A., Q1 2024 Sales/ Trading Statement Call, Apr 30, 2024 | |
Feb. 28 | Transcript : Metrovacesa S.A., 2023 Earnings Call, Feb 28, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company is in debt and has limited leeway for investment
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 38.76 times its estimated earnings per share for the ongoing year.
- For the last few months, analysts have been revising downwards their earnings forecast.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.19% | 1.4B | B+ | ||
-29.16% | 11.3B | B+ | ||
+7.32% | 10.72B | - | B- | |
-24.81% | 7.7B | - | B+ | |
-4.86% | 7.07B | C- | ||
+4.16% | 6.6B | A- | ||
-0.34% | 6.53B | C+ | ||
+15.37% | 3.74B | - | ||
-4.29% | 3.71B | C | ||
+27.20% | 3.32B | - | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MVC Stock
- Ratings Metrovacesa S.A.